BioCentury
ARTICLE | Company News

Tekmira, Pfizer deal

March 22, 2010 7:00 AM UTC

The companies will evaluate Tekmira's stable nucleic acid-lipid particle (SNALP) technology to deliver short interfering RNA molecules provided by Pfizer. Tekmira will be responsible for preparing the...